Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapeutic Evaluation of STeroids in IgA Nephropathy Global - Post-Trial ObservatioNal Cohort Study

NCT05434325 is registered in ClinicalTrials.gov with The George Institute as lead sponsor.

NCT NCT05434325
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05434325 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapeutic Evaluation of STeroids in IgA Nephropathy Global - Post-Trial ObservatioNal Cohort Study
Lead sponsor
The George Institute
Phase
Observational
Overall status
Completed
Start date
December 7, 2022
Completion date
August 30, 2025
Enrollment
211 (actual)
Sites
59

Conditions

As the registry lists them; a condition with its own page is linked.

esrd, glomerulonephritis, iga nephropathy, kidney diseases